[HTML][HTML] Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
D Planas, D Veyer, A Baidaliuk, I Staropoli… - Nature, 2021 - nature.com
The SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India 1 , 2 , 3 , 4 – 5 .
Since then, it has become dominant in some regions of India and in the UK, and has spread to …
Since then, it has become dominant in some regions of India and in the UK, and has spread to …
[HTML][HTML] Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
…, F Porrot, I Staropoli, F Lemoine, H Péré, D Veyer… - Nature, 2022 - nature.com
The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and
South Africa 1 , 2 – 3 . It has since spread to many countries and is expected to rapidly become …
South Africa 1 , 2 – 3 . It has since spread to many countries and is expected to rapidly become …
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
…, TA Szwebel, SH Merkling, JM Treluyer, D Veyer… - Science, 2020 - science.org
Coronavirus disease 2019 (COVID-19) is characterized by distinct patterns of disease
progression that suggest diverse host immune responses. We performed an integrated immune …
progression that suggest diverse host immune responses. We performed an integrated immune …
[HTML][HTML] Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies
…, M Gonzalez, J De Sèze, H Péré, D Veyer… - Nature medicine, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.7 and B.1.351 variants
were first identified in the United Kingdom and South Africa, respectively, and have since …
were first identified in the United Kingdom and South Africa, respectively, and have since …
[HTML][HTML] Serum neutralization of SARS-CoV-2 Omicron sublineages BA. 1 and BA. 2 in patients receiving monoclonal antibodies
…, M Casadevall, C Charre, H Péré, D Veyer… - Nature medicine, 2022 - nature.com
The severe acute respiratory syndrome coronavirus 2 Omicron BA.1 sublineage has been
supplanted in many countries by the BA.2 sublineage. BA.2 differs from BA.1 by about 21 …
supplanted in many countries by the BA.2 sublineage. BA.2 differs from BA.1 by about 21 …
Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
…, J London, V Zeller, D Ghez, D Veyer… - Blood, The Journal …, 2020 - ashpublications.org
Anti-CD20 monoclonal antibodies are widely used for the treatment of hematological
malignancies or autoimmune disease but may be responsible for a secondary humoral deficiency. …
malignancies or autoimmune disease but may be responsible for a secondary humoral deficiency. …
[HTML][HTML] Resistance of Omicron subvariants BA. 2.75. 2, BA. 4.6, and BQ. 1.1 to neutralizing antibodies
…, L Hocqueloux, E Simon-Loriere, D Veyer… - Nature …, 2023 - nature.com
Convergent evolution of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 lineages has led to the
emergence of several new subvariants, including BA.2.75.2, BA.4.6. and BQ.1.1. The …
emergence of several new subvariants, including BA.2.75.2, BA.4.6. and BQ.1.1. The …
[HTML][HTML] Distinct evolution of SARS-CoV-2 Omicron XBB and BA. 2.86/JN. 1 lineages combining increased fitness and antibody evasion
…, T Vanhoucke, P Rosenbaum, D Veyer… - Nature …, 2024 - nature.com
The unceasing circulation of SARS-CoV-2 leads to the continuous emergence of novel viral
sublineages. Here, we isolate and characterize XBB.1, XBB.1.5, XBB.1.9.1, XBB.1.16.1, EG.…
sublineages. Here, we isolate and characterize XBB.1, XBB.1.5, XBB.1.9.1, XBB.1.16.1, EG.…
[HTML][HTML] Nasal swab sampling for SARS-CoV-2: a convenient alternative in times of nasopharyngeal swab shortage
…, J Rodary, T Ribeyre, L Bélec, D Veyer - Journal of clinical …, 2020 - Am Soc Microbiol
Nasopharyngeal swab is the reference sampling method to detect severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), as recommended by the World Health Organization (…
syndrome coronavirus 2 (SARS-CoV-2), as recommended by the World Health Organization (…
Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization
…, F Porrot, I Staropoli, F Lemoine, H Péré, D Veyer… - BioRxiv, 2021 - biorxiv.org
The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and
South Africa 1 , 2 . It has in the meantime spread to many countries and is expected to rapidly …
South Africa 1 , 2 . It has in the meantime spread to many countries and is expected to rapidly …